Reference
1. Yang J,Zheng Y,Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis, 2020. 94: 91-95.
2. Lu R,Zhao X,Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 2020. 395(10224): 565-574.
3. Maan S,Maan N S,Nomikou K, et al. Complete genome characterisation of a novel 26th bluetongue virus serotype from Kuwait. PLoS One, 2011. 6(10): e26147.
4. Xu X,Chen P,Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci, 2020. 63(3): 457-460.
5. Wang W,Tang J,Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol, 2020. 92(4): 441-447.
6. Merad M,Martin J C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol, 2020. 20(6): 355-362.
7. Zhang Y,Bian S,Liu X, et al. Positive Rate of Different Hepatitis B Virus Serological Markers in Peking Union Medical College Hospital, a General Tertiary Hospital in Beijing. Chin Med Sci J, 2016. 31(1): 17-12.
8. Wu Z,McGoogan J M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA, 2020.
9. Zabetakis I,Lordan R,Norton C, et al. COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients, 2020. 12(5).
10. Zhou M,Zhang X,Qu J. Coronavirus disease 2019 (COVID-19): a clinical update. Front Med, 2020. 14(2): 126-135.
11. Wu C,Chen X,Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med, 2020.
12. Ruan Q,Yang K,Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med, 2020. 46(5): 846-848.
13. Zhou F,Yu T,Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020. 395(10229): 1054-1062.
14. Bourgonje A R,Abdulle A E,Timens W, et al. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol, 2020.
15. Cheng Y,Luo R,Wang K, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int, 2020. 97(5): 829-838.
16. Caccialanza R,Laviano A,Lobascio F, et al. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol. Nutrition, 2020. 74: 110835.